A Study of LM-350 in Subjects With Advanced Solid Tumours

Clinical trial NCT07112222 · RECRUITING

Trial details

NCT number: NCT07112222
Sponsor: LaNova Medicines Limited
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Tumors

Start date: 2025-08-28
Primary completion: 2028-06-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.